EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Transforming obesity: The advancement of multi-receptor drugs

Christine M Kusminski, Diego Perez-Tilve, Timo D Müller, Richard D DiMarchi, Matthias H Tschöp, Philipp E Scherer

Cell · 2024-07 · 187 (15) · 3829-3853

DOI: 10.1016/j.cell.2024.06.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell, 2024-07. Verfasst von Christine M Kusminski und 5 weiteren Autor:innen. Beteiligte Einrichtung: Touchstone Diabetes Center, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Hauptthemen laut MEDLINE: Obesity, Anti-Obesity Agents. Die Arbeit wurde bisher 128-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIA NIH HHS, ERC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityAnti-Obesity AgentsHumansAnimalsGlucagon-Like Peptide-1 ReceptorGlucagon-Like Peptide 1Adipose TissueGlucagon-Like Peptide-1 Receptor Agonists

Substanzen

Anti-Obesity AgentsGlucagon-Like Peptide-1 ReceptorGlucagon-Like Peptide 1Glucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Touchstone Diabetes Center, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Department of Pharmacology and Systems Physiology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Munich, Munich, Germany; German Center for Diabetes Research (DZD) and Walther-Straub Institute of Pharmacology and Toxicology, Ludwig-Maximilians…
  • Department of Chemistry, Indiana University, Bloomington, IN, USA.
  • Helmholtz Munich, Munich, Germany; Division of Metabolic Diseases, Department of Medicine, Technische Universität, Munich, Germany.
  • Touchstone Diabetes Center, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address: philipp.scherer@utsouthwestern.edu.

Förderung

  • NIDDK NIH HHS
  • NIA NIH HHS
  • ERC
  • NIDDK
  • Deutsches Zentrum für Diabetesforschung
  • German Research Foundation
  • California Department of Fish and Game
  • Novo Nordisk

Zitieren

APA

Kusminski, C. M., Perez-Tilve, D., Müller, T. D., DiMarchi, R. D., Tschöp, M. H., & Scherer, P. E. (2024). Transforming obesity: The advancement of multi-receptor drugs. Cell, 187(15), 3829-3853. https://doi.org/10.1016/j.cell.2024.06.003

Vancouver

Kusminski CM, Perez-Tilve D, Müller TD, DiMarchi RD, Tschöp MH, Scherer PE. Transforming obesity: The advancement of multi-receptor drugs. Cell. 2024;187(15):3829-3853. doi:10.1016/j.cell.2024.06.003

BibTeX
@article{Kusminski2024,
  author = {Kusminski, Christine M and Perez-Tilve, Diego and Müller, Timo D and DiMarchi, Richard D and Tschöp, Matthias H and Scherer, Philipp E},
  title = {Transforming obesity: The advancement of multi-receptor drugs},
  journal = {Cell},
  year = {2024},
  volume = {187},
  number = {15},
  pages = {3829--3853},
  doi = {10.1016/j.cell.2024.06.003}
}
Kostenlos starten →